Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects

British Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 310-314

  Chan, Clark ^a   Yeo, Kwee P ^a   Pan, Alan X ^a   Lim, Maggie ^a   Knadler, Mary P ^b   Small, David S ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

CYP1A2; CYP2D6; Duloxetine; Pharmacokinetics; Race

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HUMAN; JAPANESE; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ANTIDEPRESSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; RANDOMIZED CONTROLLED TRIALS; THIOPHENES;

EID: 33846957159     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02770.x     Document Type: Article

References (6)

1. Cymbalta® Package Insert. Indianapolis, IN: Eli Lilly Pharmaceuticals 2005.
2. Moore K. Duloxetine: a new approach for treating stress urinary incontinence. Int J Gynaecol Obstet 2004; 86: 53-62.
3. Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, Yeo KP, Reddy S, Lim M, Ayan-Oshodi M, Wise SD. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clin Pharmacol Ther 2003; 73: 170-7.
4. Lantz RJ, Gillespie TA, Rash TJ, Kuo F, Skinner M, Kuan HY, Knadler MP. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos 2003; 31: 1142-50.
5. Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, Stalker DJ, Wise SD, Dombey S, Loew C. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol 2003; 43: 943-67.
6. Hasler JA, Estabrook R, Murray M, Pikuleva I, Waterman M, Capdevila J, Holla V, Helvig C, Falck JR, Farrell G, Kaminsky LS, Spivack SD, Boitier E, Beaune P. Human cytochromes P450. Mol Aspects Med 1999; 20: 1-137.